JPRN-UMIN000008819
Completed
Phase 2
Study on the efficacy and safety of reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy - Reduced-fluence photodynamic therapy for chronic central serous chorioretinopathy
Kawasaki Medical School Hospital Department of Ophthalmology0 sites10 target enrollmentNovember 1, 2012
Conditionschronic central serous chorioretinopathy
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- chronic central serous chorioretinopathy
- Sponsor
- Kawasaki Medical School Hospital Department of Ophthalmology
- Enrollment
- 10
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) drug allergy to verteporfin 2\) porphyria, or hypersensitivity to artificial illumination 3\) macular diseases other than central serous chorioretinopathy 4\) pregnant or expecting pregnancy 5\) others, inappropriate case judged by investigator or subinvestigators
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
Comparison of the efficacy and safety of two different lasers in the treatment of melasmamelasma.ChloasmaIRCT201201318146N2Shahid Beheshti University of Medical Sciences50
Active, not recruiting
Phase 1
Exploratory study of the efficacy and safety of flexible doses of Milnacipran and Venlafaxine administered in out patients with Major Depressive Disorder.EUCTR2006-003658-47-FRPierre Fabre Médicament - IRPF180
Recruiting
Not Applicable
Study of efficacy and safety of dose reduction in the oral cavity by target volume definition using PET/CT for intensity-modulated radiation therapy of head and neck cancersHead-and-neck cancerJPRN-UMIN000033007Juntendo University,Graduate School of Medicine,Department of Radiation Oncology10
Recruiting
Phase 4
The investigation of safety and efficacy of short hydration GC therapy in metastatic urothelial carcinoma patientsadvanced or metastatic urothelial carcinoma patientsJPRN-UMIN000032901agoya City University Graduate School of Medical Sciences10
Completed
Phase 1
A trial to evaluate an oral medicinal cannabis extract compared with placebo for the treatment of insomnia.InsomniaNeurological - Other neurological disordersACTRN12618000078257Zelda Therapeutics Limited24